- Home
- WPP vs INDV Comparison
WPP vs INDV Comparison
Compare WPP & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$15.05
HOLD
Current Price
$29.10
Company Overview
Basic Information| Metric | WPP | INDV |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United Kingdom | United States |
| Employees | 104000 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.0B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | WPP | INDV |
|---|---|---|
| Price | $15.05 | $29.10 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 608.8K | ★ 2.8M |
| Earning Date | 02-26-2026 | 06-08-2026 |
| Dividend Yield | ★ 13.98% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.48 | N/A |
| P/E Ratio | $38.96 | ★ $18.56 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $14.81 | $8.65 |
| 52 Week High | $40.95 | $38.00 |
Technical Indicators
Market Signals| Indicator | WPP | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 30.73 | 30.20 |
| Support Level | N/A | $22.39 |
| Resistance Level | $19.55 | $35.75 |
| Average True Range (ATR) | 0.55 | 1.66 |
| MACD | -0.13 | -0.24 |
| Stochastic Oscillator | 7.98 | 6.07 |
Price Performance
Historical Comparison WPP
INDV
About WPP WPP plc
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.